S100A14 and carcinoma: In the studies of S100A14 expression, contrasting data regarding its relationship to prognosis, which were based on immunohistochemical methods of S100A14 expression, have been reported; S100A14 expression was correlated with a poorer prognosis in carcinomas of the breast, liver, and stomach [8,9,25] and with a favorable prognosis in colorectal and small intestinal carcinomas [10,11].